MD-based Celsion Corp. adds to Board of Directors

Daily Record, The (Baltimore), Jul 15, 2005 by Staff Reports

Celsion Corp., a Columbia-based biotech company developing heat- activated cancer treatment systems, added Gregory Weaver to its Board of Directors to increase the number of directors to six. The board also appointed Weaver as a member to its Audit Committee.

Weaver is currently vice president, chief financial officer and secretary of the Nastech Pharmaceutical Co., a drug delivery company focused on intranasally delivered products and technologies.

Copyright 2005 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with ProQuest